Screenshot of a prostate lesion in mint Lesion

Streamline Prostate Cancer Screenings with Prostate.Carcinoma.ai in mint Lesion

The Prostate.Carcinoma.ai plug-in, developed by our partner FUSE-AI, is a powerful addition to mint Lesion, designed specifically to enhance prostate cancer screenings. This advanced solution leverages artificial intelligence to automate and accelerate prostate MR evaluations based on the PI-RADS 2.1 guidelines, transforming the workflow and precision for radiologists.

At the click of a button, Prostate.Carcinoma.ai performs full segmentation of the prostate and its anatomical zones, and detects and segments potentially malignant lesions. mint Lesion maps each finding onto the standardized prostate lesion scheme, eliminating the need for time-consuming manual lesion annotation and drawing.

Radiologists maintain full control over the AI-generated results, with the ability to review, reject, modify, or add new findings to ensure accuracy. Based on these inputs, mint Lesion automatically calculates the PI-RADS score, delivering a comprehensive and structured report.

mint Lesion also enables longitudinal tracking of prostate lesions for MRI-based active surveillance. Radiologists can easily monitor changes in lesions over time, supporting informed decision-making for patient management and enhancing the continuity of care.

Learn more on our partner page.

Related Resources

Related Resources

Systems on FHIR: Driving Healthcare Innovation Through Interoperability

Interoperability is revolutionizing healthcare by enabling the seamless exchange of patient data across systems. This efficient data flow is critical…

Doctor looking at screen that shows medical data

Human-AI Collaboration in Prostate Cancer Diagnosis

As prostate cancer diagnosis becomes increasingly complex, the collaboration between human expertise and artificial intelligence (AI) is emerging as a…

Interdisciplinarity in healthcare

Insights into the BZKF BORN-Project – Interview with Dr. Mandy Wahlbuhl-Becker

The Bavarian Oncological Radiology Network (BORN) is enhancing cancer diagnostics in Bavaria through standardized imaging and structured reporting.  …